Eleos Health is a technology company.
Eleos Health has raised $120.0M across 3 funding rounds.
Eleos Health has raised $120.0M in total across 3 funding rounds.
Eleos Health has raised $120.0M in total across 3 funding rounds.
Eleos Health's investors include Alex, Alpha Edison, Bond, Drive Capital, Eight Roads Ventures, Ensemble VC, F-Prime Capital Partners, GreatPoint Ventures, Hamilton Lane, Highbury Group, Erel Margalit, Yoav Tzruya.
Eleos Health is a technology company building an AI-powered platform for behavioral health and post-acute care providers, automating clinical documentation to reduce administrative burdens.[1][3][4][7] It serves clinicians in substance use disorder (SUD) treatment centers, home health, hospice, palliative care, and group therapy settings, solving problems like documentation overload, clinician burnout, and compliance challenges by cutting note completion time by over 70%, doubling client engagement, and improving outcomes 3-4x.[1][2][4][6][7] With strong growth momentum—including a $60M Series C in 2024, expansion to 250+ organizations across 39 states, support for nearly 40,000 providers treating over 1 million patients, and 655,000+ hours saved in 2025—Eleos leads as the most-deployed AI platform in behavioral health.[2][4][6][8]
Eleos was co-founded by Alon Joffe (CEO) and others with a mission to empower behavioral health clinicians by slashing documentation burdens, allowing focus on patient care.[2][4][5] The idea emerged from recognizing clinician burnout and administrative overload in an underfunded $11B post-acute behavioral health market, leveraging the founders' insights into real-world treatment needs.[2][4][5] Early traction built quickly: within four years, Eleos became the most-deployed platform, supporting 120+ organizations across 30 states, backed by top investors and advised by clinical experts; pivotal moments include launching multimodal AI using the largest real-world session dataset and a randomized controlled trial proving 80% faster notes and superior outcomes.[1][2][3][4]
Eleos stands out in behavioral health AI through clinician-centric design and proven results:
Eleos rides the AI-in-healthcare wave, specializing in behavioral health—a historically under-tech'd $11B post-acute sector amid rising mental health awareness and clinician shortages.[1][3][4] Timing aligns with multimodal AI advances and post-pandemic demand for efficient, scalable care, enabling Eleos to bridge gaps in coordination, measurement, and personalization.[1][6] Market forces like burnout (affecting providers) and value-based care favor its data-driven insights, while expansions into SUD, home health, and hospice position it to influence compassionate care ecosystems by proving AI boosts revenue, outcomes, and access.[2][4][6][7]
Eleos is primed for dominance in AI-driven behavioral care, with 2025 growth (3x patients served, team to 250+) signaling acceleration via Compliance tools, group therapy, and adjacent markets like hospice.[6][8] Trends like AI agents, regulatory alignment, and personalized medicine will propel it, potentially capturing more of the underfunded post-acute space and redefining clinician workflows. Its influence may evolve from documentation leader to full care orchestration platform, empowering providers as "heroes" and scaling impact to millions—reinforcing its founding purpose amid booming demand.[2][3][4]
Eleos Health has raised $120.0M across 3 funding rounds. Most recently, it raised $60.0M Series C in January 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2025 | $60.0M Series C | Alex, Alpha Edison, Bond, Drive Capital, Eight Roads Ventures, Ensemble VC, F-Prime Capital Partners, GreatPoint Ventures, Hamilton Lane, Highbury Group, Erel Margalit, Yoav Tzruya, Maccabee Ventures, Menlo Ventures, Thylacine Capital, Uprising, VZVC, Anne Wojcicki | |
| Nov 1, 2023 | $40.0M Series B | Alex, Alpha Edison, Bond, Drive Capital, Ensemble VC, GreatPoint Ventures, Menlo Ventures, Anne Wojcicki | |
| Apr 1, 2022 | $20.0M Series A | Eight Roads Ventures, F-Prime Capital Partners, Highbury Group, Maccabee Ventures, Menlo Ventures, Thylacine Capital, Uprising, VZVC |